| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Aptevo Therapeutics Inc is a biosciences company. The company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics. Its pipeline product includes Otlertuzumab, APVO414, ROR1 Candidate, Multiple ADAPTIR Candidates, ALG.APV-527, APVO436 and APVO210.
| |